Clinisys provides a variety of secure, user-friendly software for small and large providers in the healthcare industry. Some of their applications include patient record management, mobile patient data, and billing solutions for clients from single or multi-physician clinics to government health authorities.
Headquartered in Edmonton, Alberta, Canada, IMBiotechnologies Ltd. is a privately-owned biotechnology company focused on the development and commercialization of medical devices in the area of embolotherapy. The Company’s core technology is designed for the treatment of solid malignant tumors, benign tumors such as uterine fibroids, benign prostatic hyperplasia (“BPH”), and other tissues.
Metabolomic Technologies Inc. (MTI) is a privately held Canadian company based in Edmonton, Canada. MTI specializes in metabolomics-based diagnostics for the healthcare market. MTI’s flagship product, PolypDx™, is the first and only urine-based test with a high sensitivity for detecting adenomatous polyps, the precursor to colorectal cancer (CRC). PolypDx™ provides healthcare professionals with a new tool for early screening and detection, enabling the timely removal of polyps before they progress to colorectal cancer.
Nanospeed Diagnostics provides portable, innovative, and rapid testing solutions to the healthcare sector.
Incorporated in 2009, Nanospeed has developed proprietary diagnostic/screening test kit platforms based on our Lateral Flow Immuno-Assay (LIFA) and our “Lab-On-a-Chip”(LOC) technology. These technological advancements provide our clients with cost-effective and reliable testing tools that address the increasing needs of the healthcare industry, regulatory agencies and consumers.
Umay creates products designed to treat and manage dry eye with an at-home thermal therapy that’s easily incorporated into a user’s daily life. UmayRest is the first at-home treatment to successfully treat dry eye.